A detailed history of 1832 Asset Management L.P. transactions in Zoetis Inc. stock. As of the latest transaction made, 1832 Asset Management L.P. holds 19,897 shares of ZTS stock, worth $3.64 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
19,897
Previous 61,472 67.63%
Holding current value
$3.64 Million
Previous $10.4 Million 66.84%
% of portfolio
0.01%
Previous 0.02%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$145.54 - $178.83 $6.05 Million - $7.43 Million
-41,575 Reduced 67.63%
19,897 $3.45 Million
Q1 2024

May 14, 2024

BUY
$165.67 - $199.94 $513,411 - $619,614
3,099 Added 5.31%
61,472 $10.4 Million
Q4 2023

Feb 13, 2024

SELL
$151.44 - $200.09 $7.48 Million - $9.88 Million
-49,376 Reduced 45.83%
58,373 $11.5 Million
Q3 2023

Nov 13, 2023

BUY
$167.14 - $192.77 $18 Million - $20.8 Million
107,749 New
107,749 $18.7 Million
Q2 2023

Aug 11, 2023

BUY
$160.94 - $186.23 $3.98 Million - $4.6 Million
24,714 Added 241.47%
34,949 $6.02 Million
Q1 2023

May 12, 2023

SELL
$145.48 - $175.02 $266,955 - $321,161
-1,835 Reduced 15.2%
10,235 $1.7 Million
Q4 2022

Feb 14, 2023

BUY
$131.14 - $157.47 $44,981 - $54,012
343 Added 2.92%
12,070 $1.77 Million
Q3 2022

Nov 14, 2022

SELL
$148.29 - $182.55 $229,849 - $282,952
-1,550 Reduced 11.67%
11,727 $1.74 Million
Q2 2022

Aug 15, 2022

BUY
$155.97 - $200.09 $86,251 - $110,649
553 Added 4.35%
13,277 $2.28 Million
Q1 2022

May 16, 2022

SELL
$181.39 - $234.03 $219 Million - $283 Million
-1,209,167 Reduced 98.96%
12,724 $2.37 Million
Q4 2021

Feb 15, 2022

SELL
$193.69 - $247.03 $38.6 Million - $49.3 Million
-199,459 Reduced 14.03%
1,221,891 $303 Million
Q3 2021

Nov 15, 2021

BUY
$189.29 - $209.69 $37.1 Million - $41.1 Million
196,083 Added 16.0%
1,421,350 $279 Million
Q2 2021

Aug 16, 2021

BUY
$155.9 - $187.99 $167 Million - $201 Million
1,071,708 Added 697.91%
1,225,267 $230 Million
Q1 2021

May 17, 2021

SELL
$144.0 - $169.39 $47.9 Million - $56.4 Million
-332,730 Reduced 68.42%
153,559 $24.2 Million
Q4 2020

Feb 16, 2021

SELL
$157.07 - $174.35 $223 Million - $247 Million
-1,416,600 Reduced 74.44%
486,289 $80.1 Million
Q3 2020

Nov 16, 2020

BUY
$137.1 - $165.37 $103 Million - $124 Million
750,790 Added 65.17%
1,902,889 $311 Million
Q2 2020

Aug 14, 2020

SELL
$111.92 - $142.53 $77 Million - $98.1 Million
-688,255 Reduced 37.4%
1,152,099 $153 Million
Q1 2020

May 26, 2020

BUY
$92.66 - $144.94 $170 Million - $266 Million
1,836,573 Added 48573.74%
1,840,354 $216 Million
Q1 2020

May 14, 2020

SELL
$92.66 - $144.94 $128 Million - $200 Million
-1,380,916 Reduced 99.73%
3,781 $448,000
Q4 2019

Feb 14, 2020

SELL
$116.25 - $133.25 $56.5 Million - $64.8 Million
-485,929 Reduced 25.98%
1,384,697 $184 Million
Q3 2019

Nov 14, 2019

BUY
$112.57 - $128.43 $2.39 Million - $2.73 Million
21,262 Added 1.15%
1,870,626 $232 Million
Q2 2019

Aug 14, 2019

BUY
$97.98 - $114.28 $181 Million - $211 Million
1,845,879 Added 52966.4%
1,849,364 $209 Million
Q1 2019

May 15, 2019

SELL
$81.56 - $100.67 $167 Million - $206 Million
-2,051,168 Reduced 99.83%
3,485 $305,000
Q4 2018

Feb 14, 2019

SELL
$79.28 - $95.27 $1.76 Million - $2.12 Million
-22,255 Reduced 1.07%
2,054,653 $176 Million
Q3 2018

Nov 14, 2018

BUY
$83.5 - $93.23 $16.4 Million - $18.3 Million
196,524 Added 10.45%
2,076,908 $190 Million
Q2 2018

Aug 14, 2018

BUY
$79.9 - $89.2 $31.2 Million - $34.8 Million
389,914 Added 26.16%
1,880,384 $160 Million
Q1 2018

May 15, 2018

SELL
$71.51 - $84.69 $1.05 Million - $1.24 Million
-14,687 Reduced 0.98%
1,490,470 $125 Million
Q4 2017

Feb 14, 2018

SELL
$63.24 - $72.8 $12.2 Million - $14.1 Million
-193,310 Reduced 11.38%
1,505,157 $108 Million
Q3 2017

Nov 14, 2017

BUY
$59.73 - $65.4 $101 Million - $111 Million
1,698,467
1,698,467 $105 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $85.6B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track 1832 Asset Management L.P. Portfolio

Follow 1832 Asset Management L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of 1832 Asset Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on 1832 Asset Management L.P. with notifications on news.